Clinical trial
Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating…
NCT00072020 · University of Sheffield, Other · Unknown status
Key facts
| NCT number | NCT00072020 |
|---|---|
| Title | Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer |
| Official title | Does Adjuvant Zoledronic Acid Reduce Recurrence in Patients With High Risk Localized Breast Cancer? |
| Lead sponsor | University of Sheffield, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Metastatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | zoledronic acid, adjuvant therapy, neoadjuvant therapy |
| Start date | Aug 1, 2003 |
| First posted | Nov 6, 2003 |
| Last update posted | Aug 2, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: